Combining bioreductive drugs and radiation for the treatment of solid tumors

This publication has 57 references indexed in Scilit:

• Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours
  Gene Therapy, 2002
• Hypoxia as a target for combined modality treatments
  European Journal Of Cancer, 2002
• Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9
  General Pharmacology: The Vascular System, 1996
• Hypoxia-specific cytotoxins in cancer therapy
  Seminars in Radiation Oncology, 1996
• Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954
  European Journal Of Cancer, 1995
• Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia
  European Journal Of Cancer, 1994
• Phase I and Pharmacologic Study of the Novel Indoloquinone Bioreductive Alkylating Cytotoxic Drug E09
  JNCI Journal of the National Cancer Institute, 1994
• Unusually marked hypoxic sensitization to indoloquinone E09 and mitomycin C in a human colon‐tumour cell line that lacks DT‐diaphorase activity
  International Journal of Cancer, 1994
• Tumour Hypoxia: The Picture Has Changed in the 1990s
  International Journal of Radiation Biology, 1994
• Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro
  International Journal of Cancer, 1986